To evaluate the effectiveness of CANT1 as a biomarker for HCC, our team examined the AUC, with the AUC values at 1-, 2-, and 3-year survival being 0.686, 0.61, and 0.633, respectively(Fig. 2C). This evidence concerns the gene CANT1 and hepatocellular carcinoma.